Celsion Corporation (CLSN) financial statements (2022 and earlier)

Company profile

Business Address 997 LENOX DRIVE
LAWRENCEVILLE, NJ 08648
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:56,90017,16414,81827,58224,2004,30020,065
Cash and cash equivalents19,58617,1646,87513,35411,4442,6249,265
Short-term investments29,811 7,94314,22812,7241,68010,800
Other undisclosed cash, cash equivalents, and short-term investments7,503   32(4) 
Receivables2,4471,6611,353451898989
Other undisclosed current assets(7,402) 649823123127
Total current assets:51,94618,82516,23528,13124,3124,51320,281
Noncurrent Assets
Operating lease, right-of-use asset  1,432
Property, plant and equipment477295    855
Intangible assets, net (including goodwill)  18,05418,28123,01825,7661,990
Goodwill  1,9761,9761,9761,9761,976
Intangible assets, net (excluding goodwill)  16,07716,30521,04223,78914
Deposits noncurrent assets  333259 914
Deferred costs      26
Deferred income tax assets  1,819
Other noncurrent assets21,62418,408  9  
Other undisclosed noncurrent assets     10025,033
Total noncurrent assets:22,10118,70221,63818,54023,02725,87427,918
Other undisclosed assets  405185176463855
TOTAL ASSETS:74,04737,52738,27846,85647,51430,85049,055
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities5,7214,7035,1665,6075,7005,3634,750
Accounts payable2,5472,2452,8633,0213,4172,8792,830
Accrued liabilities3,1742,4592,3042,5862,2832,4841,920
Deferred revenue500500500
Debt 1,1172,228  2,5614,100
Deferred revenue and credits500500500
Contract with customer, liability500
Other undisclosed current liabilities549433     
Total current liabilities:6,7706,7537,8946,1076,2008,4239,350
Noncurrent Liabilities
Long-term debt and lease obligation6,0854,6459,1079,417  2,350
Long-term debt, excluding current maturities5,8543,9347,9639,417  2,350
Operating lease, liability2317101,144
Liabilities, other than long-term debt5,3967,5186,7188,97114,61015,70116,969
Deferred revenue and credits2,0002,5003,000
Deferred revenue 5001,000
Other liabilities   63721248
Business combination, contingent consideration, liability5,3967,0185,7188,90812,53913,18813,921
Other undisclosed noncurrent liabilities   1,500   
Total noncurrent liabilities:11,48112,16315,82519,88814,61015,70119,319
Total liabilities:18,25118,91623,71925,99520,81024,12428,669
Stockholders' equity
Stockholders' equity attributable to parent55,79618,61114,55920,86126,7056,72620,386
Common stock58407233188173312234
Treasury stock, value(85)(85)(85)(85)(85)(85)(1,382)
Additional paid in capital388,601330,290304,886294,393288,409247,878239,668
Accumulated other comprehensive income (loss)(8) 4330(10) (4)
Accumulated deficit(332,770)(312,000)(290,517)(273,665)(261,782)(241,380)(218,130)
Total stockholders' equity:55,79618,61114,55920,86126,7056,72620,386
TOTAL LIABILITIES AND EQUITY:74,04737,52738,27846,85647,51430,85049,055

Income statement (P&L) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues500500500500500500500
Revenue, net500500500
Gross profit:500500500500500500500
Operating expenses(21,507)(18,986)(21,065)(21,565)(18,968)(21,150)(21,347)
Operating loss:(21,007)(18,486)(20,565)(21,065)(18,468)(20,650)(20,847)
Nonoperating income (expense)(1,146)(4,843)1,897(1,237)(1,934)(1,404)(1,614)
Investment income, nonoperating11120501354262764
Interest and debt expense(234)(1,292)(1,393)(712)(92)(723)(1,357)
Loss from continuing operations before equity method investments, income taxes:(22,387)(24,622)(20,061)(23,014)(20,494)(22,777)(23,818)
Other undisclosed income from continuing operations before income taxes2341,2921,393712   
Loss from continuing operations before income taxes:(22,153)(23,329)(18,668)(22,302)(20,494)(22,777)(23,818)
Income tax benefit1,3831,8461,81610,419   
Net loss:(20,769)(21,484)(16,852)(11,883)(20,494)(22,777)(23,818)
Other undisclosed net income attributable to parent    927231,357
Net loss attributable to parent:(20,769)(21,484)(16,852)(11,883)(20,402)(22,054)(22,461)
Other undisclosed net loss available to common stockholders, basic    (346)  
Net loss available to common stockholders, diluted:(20,769)(21,484)(16,852)(11,883)(20,748)(22,054)(22,461)

Comprehensive Income ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net loss:(20,769)(21,484)(16,852)(11,883)(20,494)(22,777)(23,818)
Other comprehensive income     412
Comprehensive loss:(20,769)(21,484)(16,852)(11,883)(20,494)(22,773)(23,806)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent8(43)1340827231,357
Comprehensive loss, net of tax, attributable to parent:(20,761)(21,526)(16,839)(11,843)(20,412)(22,050)(22,449)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: